China, Oct. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134832
Registration Time: 2026/10/21
Type: Interventional study
Primary Sponsor: The Fifth Affiliated Hospital, Sun Yat-Sen University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343478
Published by HT Digital Content Services with permission from Health Daily Digest....